GI
TXG icon

GAMMA Investing’s 10x Genomics TXG Stock Holding History

GAMMA Investing’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
4,294
+101
+2% +$2.65K 0.01% 1421
2026
Q1 		$89K Buy
4,193
+253
+6% +$5.06K ﹤0.01% 1774
2025
Q4 		$64.3K Buy
3,940
+292
+8% +$4.41K ﹤0.01% 1896
2025
Q3 		$42.6K Sell
3,648
-39
-1% -$509 ﹤0.01% 2104
2025
Q2 		$42.7K Buy
3,687
+101
+3% +$921 ﹤0.01% 2027
2025
Q1 		$31.3K Buy
3,586
+1,614
+82% +$20.3K ﹤0.01% 2124
2024
Q4 		$28.3K Buy
1,972
+427
+28% +$6.74K ﹤0.01% 2080
2024
Q3 		$34.9K Buy
1,545
+1,265
+452% +$26.2K ﹤0.01% 1744
2024
Q2 		$5.45K Sell
280
-292
-51% -$7.65K ﹤0.01% 2543
2024
Q1 		$21.5K Sell
572
-270
-32% -$11.9K ﹤0.01% 1607
2023
Q4 		$35.1K Buy
+842
New +$36.6K 0.01% 1125

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GAMMA Investing's TXG Position: Q2 2026 in Review

GAMMA Investing increased its 10x Genomics (TXG) stake by 2.4% in Q2 2026, buying an estimated $2.65K and bringing the position to 4,294 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #1421.

GAMMA Investing first reported a position in TXG in Q4 2023 and has held it in 11 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • GAMMA Investing held 4,294 shares of 10x Genomics worth $165K as of Q2 2026.
  • GAMMA Investing bought 101 10x Genomics shares in Q2 2026, an estimated $2.65K.
  • 10x Genomics made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1421 holding.
  • GAMMA Investing first reported a position in 10x Genomics in Q4 2023 and has held it in 11 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.